Low molecular weight heparin
Revision as of 13:41, 7 January 2014 by Rossdonaldson1 (talk | contribs) (Rossdonaldson1 moved page Low Molecular Weight Heparin to Low Molecular Weight Heparin (Lovenox))
Background
- Similar mechanism of action as heparin but with predictable effect
- Advantages over unfractionated heparin:
- More reliable level of anticoagulation
- No need for monitoring w/ PTT
- Decreased incidence of HIT
- Can give as oupt
- Disadvantages compared to unfractionated heparin:
- Renally excreted; may accumulate in pts w/ renal impairment leading to bleeding
- Longer half-life
Dosing
- Renal impairment (Cr clearance <30)
- Use 50% of usual dose or use UFH instead
- Obesity
- Weight-based dosing safe up to 190kg (no data available thereafter)
Treatment
Complications
- Bleeding
- Less common than with UFH
- Treatment
- Protamine
- Does not completely reverse LMWHs
- Carries significant anaphylaxis risk (0.2%); only use for major bleeding
- Dosing
- For Enoxaparin: protamine 1mg IV for every 1mg of enoxaparin given in previous 8h
- If 8–12h since last enoxaparin dose give 0.5mg IV for every 1mg of enoxaparin given
- For Enoxaparin: protamine 1mg IV for every 1mg of enoxaparin given in previous 8h
- Protamine
- Pruritus
- Local skin reaction
See Also
Source
Tintinalli
